How an IISc Cow Gut Enzyme Breakthrough Beats Superbugs
Researchers at the Indian Institute of Science have discovered that a cow gut enzyme can disrupt resilient bacterial biofilms. Consequently, this biochemical innovation offers fresh hope against multidrug-resistant hospital pathogens. The team evaluated pathogens such as Acinetobacter baumannii and Klebsiella pneumoniae.
Biofilms represent complex microbial communities encased in extracellular matrix shields. Because polysaccharides form up to 95 percent of this matrix, standard antibiotic therapies struggle to penetrate. Furthermore, immune cells fail to clear these stubborn aggregates effectively.
How the Cow Gut Enzyme Dismantles Bacterial Defenses
Microbes residing within the bovine rumen naturally digest tough plant polysaccharides. Therefore, IISc researchers mined genomic data to isolate catalytic enzymes targeting similar sugar linkages. Specifically, they identified Cow Rumen Hydrolase against Acinetobacter baumannii, designated as CRhAB.
Instead of directly killing bacteria, this enzyme degrades their defensive matrix. As a result, the pathogen becomes highly vulnerable to conventional antibiotics. In addition, the enzyme suppresses key biofilm-related gene expression without imposing heavy selective pressure.
Translational Applications from Gauze to Inhalers
The research team has already created bioactive gauze dressings infused with the enzyme. In preclinical wound models, these dressings significantly accelerated bacterial clearance. Moreover, investigators are formulating advanced therapeutic patches tailored for persistent diabetic foot ulcers.
Additionally, scientists are exploring aerosolized delivery systems for pulmonary infections. An inhalable formulation could break biofilm barriers directly inside infected lungs. Ultimately, this approach may revitalise existing antimicrobial arsenals across clinical settings.
Frequently Asked Questions
Q1: What makes bacterial biofilms so difficult to treat?
Biofilms secrete a dense extracellular protective matrix consisting of polysaccharides, proteins, and DNA. Consequently, antibiotics and immune cells cannot penetrate the barrier effectively.
Q2: How does the cow gut enzyme assist existing antibiotics?
The enzyme selectively breaks down polysaccharide structural bonds within the biofilm. Therefore, it exposes vulnerable bacteria to standard antimicrobial therapies.
Q3: Which clinical applications are researchers currently pursuing?
Scientists are developing bioactive wound dressings for diabetic ulcers and nebulised formulations for deep respiratory tract infections.
References
- Cow gut enzyme may help fight stubborn infections: IISc study - ETHealthworld
- Indian Institute of Science (IISc). Breaking down bacterial barriers using bovine gut enzyme. IISc Research Communications.
- npj Biofilms and Microbes. Enzymatic disruption of multidrug-resistant bacterial biofilms using rumen-derived hydrolases. Nature Portfolio.
